Possible online services disruption due to Internet related outage
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 24, 2010
Drug Name | Review Type | Class | Manufacturer |
---|---|---|---|
Bepreve | New Drug Initial Review | Ophthalmic - Allergic Conjunctivitis | Ista |
Vivitrol | New Drug Initial Review | Opioid Antagonist | Alkermes |
Colcrys | New Drug Initial Review | Anti-Gout | URL |
Sabril | New Drug Initial Review | Anticonvulsant | Lundbeck |
Twynsta | New Drug Initial Review | Antihypertensive Combination | Boehringer Ingelheim |
Apriso | New Drug Initial Review | Ulcerative Colitis | Salix |
Besivance | New Drug Appeal | Ophthalmic Fluoroquinolone | Bausch & Lomb |
Ranexa | New Drug Appeal | Anti-Anginal | Giliead |
Vimpat | New Drug Appeal | Anticonvulsant | UCB |
Lamictal XR | New Drug Appeal | Anticonvulsant | GlaxoSmithKline |
Ulesfia | New Drug Appeal | Pediculocide | Shionogi |
Zenpep | New Drug Appeal | Pancreatic Enzyme | Eurand |
Xibrom | PDL Appeal | Ophthalmic � Anti-Inflammatory | Ista |
Istalol | PDL Appeal | Ophthalmic � Glaucoma Agent | Ista |